共 440 条
[21]
Brannagan TH(2016)A new equation to estimate muscle mass from creatinine and cystatin C PLoS ONE 113 123-165
[22]
Litchy WJ(2000)Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism Am J Clin Pathol 80 155-269
[23]
Whelan C(1995)Identification and characterization of a spinal muscular atrophy-determining gene Cell 16 265-1174
[24]
Drachman BM(1997)Correlation between severity and SMN protein level in spinal muscular atrophy Nat Genet 91 1166-1865
[25]
Adams D(2020)Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 J Neurol Neurosurg Psychiatry 63 1856-452
[26]
Heitner SB(2017)Cerebrospinal fluid total protein reference intervals derived from 20 years of patient data Clin Chem 11 443-635
[27]
Conceição I(2012)Childhood spinal muscular atrophy: controversies and challenges Lancet Neurol 378 625-157
[28]
Schmidt HH(2018)Nusinersen versus sham control in later-onset spinal muscular atrophy N Engl J Med 21 152-428
[29]
Vita G(2010)A laboratory evaluation into the short activated partial thromboplastin time Blood Coagul Fibrinolysis 2 423-225
[30]
Campistol JM(1992)International SMA consortium meeting. (26–28 June 1992, Bonn, Germany) Neuromuscul Disord 11 296-381